NVG-291 Trial in MS Patients Anticipated & How To Improve MS Patient-Provider Relationships

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291, an experimental therapy to promote nervous system repair, has been well-tolerated in an ongoing Phase 1 study in healthy volunteers.He also reads the latest MS News Today’s Expert Voices article. In this instalment, Annie Brewster, MD, who also has MS, shares her tips on how to improve patient-provider relationships.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/